Washington, D.C., July 16, 2018 – The Alliance for Aging Research submitted comments in response to the Trump administration’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket (OOP) Costs, which aims to reduce prescription drug prices and modify Medicare Part D, which provides prescription drug coverage to older adults.
Find a full copy of the comments here.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org
Vice President of Communications